Spectral Medical Inc. (TSX:EDT)
Canada · Delayed Price · Currency is CAD 1.030
+0.060 (6.19%)
Nov 9, 2026, 9:30 AM EST
Spectral Medical Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.17 | 2.44 | 2.29 | 1.6 | 1.67 | 2 | |
Revenue Growth | -19.81% | 6.82% | 43.05% | -4.14% | -16.48% | -5.00% |
Cost of Revenue | 1 | 1.12 | 1.57 | 0.94 | 0.68 | 0.79 |
Gross Profit | 1.17 | 1.33 | 0.71 | 0.66 | 0.98 | 1.21 |
Selling, General & Admin | 7.92 | 9.94 | 10.19 | 9.8 | 7.44 | 5.76 |
Other Operating Expenses | 0.3 | 0.27 | 0.74 | 0.32 | - | - |
Operating Expenses | 10.79 | 12.5 | 12.79 | 11.82 | 8.86 | 7.26 |
Operating Income | -9.62 | -11.18 | -12.08 | -11.16 | -7.88 | -6.05 |
Interest Expense | -6.82 | -5.16 | -3.18 | -1.33 | -0.18 | -0.03 |
Interest & Investment Income | 5.39 | 5.39 | - | - | - | - |
Earnings From Equity Investments | - | - | - | -0.4 | 1 | - |
Currency Exchange Gain (Loss) | -1.52 | 2.06 | -1.93 | 0.13 | -0.04 | -0.05 |
Other Non Operating Income (Expenses) | 12.22 | -38.8 | 1.79 | -2.15 | -0.36 | -0.7 |
EBT Excluding Unusual Items | -0.34 | -47.69 | -15.4 | -14.91 | -7.46 | -6.83 |
Gain (Loss) on Sale of Investments | - | - | - | -0.6 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.17 | 0.03 |
Asset Writedown | - | - | - | - | - | -0.16 |
Pretax Income | -0.34 | -47.69 | -15.4 | -15.51 | -7.63 | -6.96 |
Earnings From Continuing Operations | -0.34 | -47.69 | -15.4 | -15.51 | -7.63 | -6.96 |
Earnings From Discontinued Operations | -0.01 | -0 | -0.01 | -0.16 | -3.65 | -1.83 |
Net Income | -0.35 | -47.69 | -15.4 | -15.66 | -11.28 | -8.79 |
Net Income to Common | -0.35 | -47.69 | -15.4 | -15.66 | -11.28 | -8.79 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 264 | 287 | 281 | 279 | 270 | 252 |
Shares Outstanding (Diluted) | 264 | 287 | 281 | 279 | 270 | 252 |
Shares Change | -7.50% | 2.18% | 0.90% | 3.23% | 6.88% | 8.59% |
EPS (Basic) | -0.00 | -0.17 | -0.05 | -0.06 | -0.04 | -0.03 |
EPS (Diluted) | -0.00 | -0.17 | -0.05 | -0.06 | -0.04 | -0.03 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -9.48 | -9.52 | -8.85 | -10.91 | -9.93 | -9.18 |
Free Cash Flow Per Share | -0.04 | -0.03 | -0.03 | -0.04 | -0.04 | -0.04 |
Gross Margin | 53.99% | 54.30% | 31.19% | 41.43% | 58.97% | 60.47% |
Operating Margin | -443.38% | -457.62% | -528.21% | -698.06% | -472.71% | -303.26% |
Profit Margin | -15.95% | -1952.99% | -673.75% | -980.10% | -676.73% | -440.13% |
Free Cash Flow Margin | -437.21% | -390.01% | -386.92% | -682.48% | -595.86% | -460.12% |
EBITDA | -9.49 | -11.05 | -11.95 | -11.04 | -7.7 | -5.85 |
EBITDA Margin | - | - | - | - | - | -293.19% |
D&A For EBITDA | 0.13 | 0.13 | 0.13 | 0.11 | 0.18 | 0.2 |
EBIT | -9.62 | -11.18 | -12.08 | -11.16 | -7.88 | -6.05 |